Elizabeth J. Davis

机构：Vanderbilt University Medical Center · ORCID：0000-0001-7626-2435

发表论文 179 篇 · 总被引 11931 次 · h-index 28

代表论文

• A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma (2024 · Clinical Cancer Research · 被引 23)
• Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma (2024 · Current Treatment Options in Oncology · 被引 21)
• Olaparib in treatment‐refractory isocitrate dehydrogenase 1 ( IDH1 )– and IDH2 ‐mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trial (2025 · Cancer · 被引 13)
• Alliance A091902: A multicenter randomized phase II trial of paclitaxel (P) with or without nivolumab (N) in patients (pts) with advanced angiosarcoma (AS). (2024 · Journal of Clinical Oncology · 被引 8)
• Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer (2025 · ESMO Open · 被引 7)
• Abstract CT059: Phase 1b trial Mipasetamab Uzoptirine (ADCT-601-102) dose escalation in patients with advanced bone and soft tissue sarcomas (2024 · Cancer Research · 被引 7)